Literature DB >> 22711586

Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Heiner Claessen1, Jutta Genz, Bernd Bertram, Christoph Trautner, Guido Giani, Iris Zöllner, Andrea Icks.   

Abstract

The objectives of this study are to estimate the recent population-based incidences of all-cause and cause-specific blindness in Germany and compare them with results from a similar study conducted in 1994-1998. All blindness allowance recipients newly registered between January 2008 and December 2009 in a region in southern Germany (population, approximately 3.5 million) were assessed and their ophthalmological reports reviewed. The main causes of blindness were identified and their incidences estimated. There were 572 newly registered cases of blindness allowance. The all-cause incidence of blindness (per 100,000 person-years) in the general population was 8.4 (95 % confidence interval, 7.8-9.2), and the highest incidences were for macular degeneration (3.4; 3.0-3.9), diabetic retinopathy (0.8; 0.6-1.1) and glaucoma (0.7; 0.5-0.9). During the last two decades, blindness incidences decreased for all the main causes (standardised to the West German population 1991: 12.3; 11.9-12.7 in 1994-1998 vs. 7.3; 6.7-8.0 in 2008-2009). The highest absolute decrease was for macular degeneration and the highest relative decrease was for cataract. The most frequent main causes of blindness in Germany remained macular degeneration, diabetic retinopathy and glaucoma. Our findings suggest a remarkable decrease in the incidences of blindness, probably because of new diagnostic options and effective treatments.

Entities:  

Mesh:

Year:  2012        PMID: 22711586     DOI: 10.1007/s10654-012-9705-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  24 in total

Review 1.  [Temporal trends in the etiology of blindness].

Authors:  H G Krumpaszky
Journal:  Klin Monbl Augenheilkd       Date:  1997-02       Impact factor: 0.700

2.  Incidence of blindness in southern Germany between 1990 and 1998.

Authors:  C Trautner; B Haastert; G Giani; M Berger
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

3.  Blindness and low vision in Germany 1993-2009.

Authors:  Christian Wolfram; Norbert Pfeiffer
Journal:  Ophthalmic Epidemiol       Date:  2012-02       Impact factor: 1.648

4.  Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study.

Authors:  Helena Buch
Journal:  Acta Ophthalmol Scand       Date:  2005-06

5.  Time trends in the incidence and causes of blindness in Israel.

Authors:  Alon Skaat; Angela Chetrit; Michael Belkin; Michael Kinori; Ofra Kalter-Leibovici
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

6.  Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003.

Authors:  Rahamim Avisar; Ronit Friling; Moshe Snir; Inbal Avisar; Dov Weinberger
Journal:  Isr Med Assoc J       Date:  2006-12       Impact factor: 0.892

7.  Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study.

Authors:  Elin Gunnlaugsdottir; Arsaell Arnarsson; Fridbert Jonasson
Journal:  Acta Ophthalmol       Date:  2009-02-11       Impact factor: 3.761

8.  Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.

Authors:  Michael S Ip; Ingrid U Scott; Gary C Brown; Melissa M Brown; Allen C Ho; Suber S Huang; Franco M Recchia
Journal:  Ophthalmology       Date:  2008-10       Impact factor: 12.079

9.  Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.

Authors:  Shan C Lin; Kuldev Singh; Henry D Jampel; Elizabeth A Hodapp; Scott D Smith; Brian A Francis; David K Dueker; Robert D Fechtner; John S Samples; Joel S Schuman; Don S Minckler
Journal:  Ophthalmology       Date:  2007-10       Impact factor: 12.079

10.  Time-trend and variations in the proportion of second-eye cataract surgery.

Authors:  Lorena Hoffmeister; Rubén Román; Mercè Comas; Francesc Cots; Enrique Bernal-Delgado; Xavier Castells
Journal:  BMC Health Serv Res       Date:  2007-04-13       Impact factor: 2.655

View more
  15 in total

1.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

2.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

3.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

4.  The Foundation in Evidence of Medical and Dental Telephone Consultations.

Authors:  Martina Albrecht; Florian Isenbeck; Jüürgen Kasper; Ingrid Mühlhauser; Anke Steckelberg
Journal:  Dtsch Arztebl Int       Date:  2016-06-06       Impact factor: 5.594

5.  Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis.

Authors:  K Kostev; W Rathmann
Journal:  Diabetologia       Date:  2012-10-06       Impact factor: 10.122

6.  The Prevalence of Visual Impairment in the Adult Population.

Authors:  Christian Wolfram; Alexander K Schuster; Heike M Elflein; Stefan Nickels; Andreas Schulz; Philipp S Wild; Manfred E Beutel; Maria Blettner; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2019-04-26       Impact factor: 5.594

Review 7.  [Possibilities and limitations of glaucoma surgery].

Authors:  L Reznicek; Y Boghos; I M Lanzl
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

8.  [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices].

Authors:  B Bertram; C Gante; R-D Hilgers
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

Review 9.  Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany).

Authors:  Heiner Claessen; Tatjana Kvitkina; Maria Narres; Christoph Trautner; Bernd Bertram; Andrea Icks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-25       Impact factor: 3.117

10.  [Pattern laser trabeculoplasty and argon laser trabeculoplasty for treatment of glaucoma].

Authors:  C E Barbu; W Rasche; P Wiedemann; J Dawczynski; J D Unterlauft
Journal:  Ophthalmologe       Date:  2014-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.